Medicare Enrolled
Dr. Mher Vartivarian, D.P.M.
Foot & Ankle Surgery Podiatrist · San Francisco, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vartivarian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vartivarian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vartivarian
Dr. Mher Vartivarian is a foot & ankle surgery podiatrist in San Francisco, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Vartivarian performed 2,470 Medicare services across 1,318 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vartivarian received a total of $10,706 from 50 pharmaceutical and/or device companies across 236 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in foot & ankle surgery podiatrist. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vartivarian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 27% volume in CA
$10,706 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,470
Medicare services
Top 27% in CA for foot & ankle surgery podiatrist
1,318
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~165 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
519 | $83 | $324 |
| Toenail/fingernail removal, 6+ nails Surgical removal of six or more fingernails or toenails. This procedure involves the excision of multiple nails during a single session. |
312 | $40 | $162 |
| Removal of thickened skin growths, 2-4 This procedure involves the removal of two to four benign, thickened skin growths. It is a minor surgical intervention to eliminate non-cancerous skin lesions. |
216 | $78 | $324 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
198 | $118 | $456 |
| Vein wound compression bandage application, lower leg, ankle, and foot Application of compression bandages to the lower leg, ankle, and foot to manage vein-related wounds. |
189 | $113 | $523 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
145 | $72 | $237 |
| Removal of noncancer thickened skin growth, 1 growth This procedure involves the removal of a single benign, thickened skin growth. It is a minor surgical intervention to eliminate the lesion. |
91 | $68 | $285 |
| Toenail/fingernail removal, 1-5 nails This procedure involves the removal of one to five fingernails or toenails. |
87 | $32 | $120 |
| Functional capacity test, per 15 minutes A test or measurement to assess functional capacity. The service is billed for each 15-minute increment. |
83 | $29 | $108 |
| Trimming of dystrophic nails Trimming of dystrophic nails, any number |
82 | $17 | $90 |
| Foot X-ray, 3+ views An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints. |
74 | $33 | $136 |
| Removal of more than 4 noncancerous thickened skin growths This procedure involves the removal of more than four noncancerous thickened skin growths. It is a surgical intervention to eliminate benign skin lesions. |
69 | $88 | $352 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
67 | $100 | $397 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
63 | $116 | $447 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
49 | $54 | $204 |
| Wound tissue removal, 20 sq cm or less This procedure involves the removal of tissue from a wound area measuring 20 square centimeters or less. |
45 | $100 | $392 |
| Strapping, unna boot | 39 | $81 | $271 |
| Skin substitute graft application, 25 sq cm or less Application of a skin substitute graft to a wound on the trunk, arms, or legs covering 25 square centimeters or less. |
36 | $152 | $578 |
| Therapy procedure using ultrasound A therapeutic treatment that utilizes ultrasound technology. The specific clinical purpose or condition treated is not defined in the provided description. |
28 | $494 | $1,858 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $147 | $586 |
| Skin and tissue removal, 20 sq cm or less This procedure involves the surgical excision of skin and underlying tissue from an area measuring 20 square centimeters or smaller. |
23 | $122 | $497 |
| X-ray of foot, 2 views An X-ray imaging test of the foot using two different angles to create pictures of the bones and joints. |
17 | $30 | $110 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
13 | $157 | $663 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,706
Total received (2018-2024)
Avg $1,529/year across 7 years
Top 12% in CA for foot & ankle surgery podiatrist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
236
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,706 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,609
2023
$1,455
2022
$1,467
2021
$591
2020
$1,199
2019
$2,519
2018
$866
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Voom Medical Devices, Inc.
$538
Orthofix Medical, Inc.
$388
Stryker Corporation
$340
Alafair Biosciences, Inc.
$272
Smith+Nephew, Inc.
$199
Paragon 28, Inc.
$199
EXACTECH, INC.
$171
Kerecis Limited
$92
DePuy Synthes Sales Inc.
$86
Integra LifeSciences Corporation
$82
Bioventus LLC
$58
Evolution Surgical, Inc
$45
Aroa Biosurgery Incorporated
$37
Urgo Medical North America, LLC
$28
Nevro Corp.
$28
Novo Nordisk Inc
$24
ConvaTec Inc.
$21
Top 3 companies account for 48.5% of 2024 payments
All-time payments by company (2018-2024) ›
Smith+Nephew, Inc.
$2,920
Osiris Therapeutics Inc.
$1,291
Voom Medical Devices, Inc.
$538
Paragon 28, Inc.
$515
Stryker Corporation
$451
TREACE MEDICAL CONCEPTS, INC.
$443
Orthofix Medical, Inc.
$388
Nevro Corp.
$355
Alafair Biosciences, Inc.
$272
Kerecis Limited
$243
Takeda Pharmaceuticals U.S.A., Inc.
$220
Medline Industries, Inc.
$193
Boehringer Ingelheim Pharmaceuticals, Inc.
$191
Organogenesis Inc.
$180
Musculoskeletal Transplant Foundation Inc.
$179
EXACTECH, INC.
$171
DePuy Synthes Sales Inc.
$153
CROSSROADS EXTREMITY SYSTEMS, LLC
$152
Terumo BCT, Inc.
$145
ORGANOGENESIS INC.
$141
Novo Nordisk Inc
$128
Bioventus LLC
$126
Integra LifeSciences Corporation
$120
Melinta Therapeutics, LLC
$117
Merck Sharp & Dohme Corporation
$105
AbbVie Inc.
$94
PolarityTE, Inc.
$85
Amgen Inc.
$69
ABBVIE INC.
$60
Zimmer Biomet Holdings, Inc.
$57
Melinta Therapeutics, Inc.
$54
Aroa Biosurgery Incorporated
$53
Evolution Surgical, Inc
$45
Wright Medical Technology, Inc.
$37
ConvaTec Inc.
$36
Tactile Systems Technology Inc
$35
Smith & Nephew, Inc.
$32
Derma Sciences, Inc.
$31
NESTLE HEALTHCARE NUTRITION INC.
$30
Abbott Laboratories
$29
Urgo Medical North America, LLC
$28
Biohaven Pharmaceutical Holding Company Ltd.
$28
Medline Industries LP
$26
Nestle HealthCare Nutrition Inc.
$26
Milliken Healthcare Products, LLC
$26
Ortho Dermatologics, a division of Bausch Health US, LLC
$22
GRT US Holding, Inc.
$19
KCI USA, Inc.
$19
MEDELA LLC
$13
Misonix Inc
$13
Top 3 companies account for 44.4% of all-time payments
Associated products mentioned in payments ›
3M Coban · AMNIOEXCEL · AQUACEL AG+ · AccelStim · Amitiza · Amnio Repair · Ankle Fracture · Apligraf · Baxdela · Biomet Orthopak · Bone Marrow Aspirate Concentrate System · COLLAGENASE SANTYL · CORE · CROSSCHECK · DEXILANT · Dexilant · EVENITY · EXOGEN ULTRASOUND BONE HEALING SYSTEM · EXTERNAL FIXATION · Exogen · Exogen Ultrasound Bone Healing System · FLEXITOUCH · GORILLA · GORILLA MTP · GRAFIX · GRAFIX PL · GRAFIX/GRAFIXPL/STRAVIX · Grafix PL PRIME · GrafixPL · Hyalomatrix Wound Device · INC. · INFINITY · INNOVAMATRIX AC · Integra · JANUVIA · JARDIANCE · JUBLIA · Kerecis Omega3 SurgiClose · Kimyrsa · LAPIPLASTY SYSTEM · MEDLINE INDUSTRIES · MOTEGRITY · MOTOBAND CP · Medical Implant · NURTEC ODT · OMNIGRAFT · ORTHOLOC 2 LAPIFUSE · Omnia · Orbactiv · Ozempic · PARATROOPER · PICO · PROSTEP MICA · Physio-Stim · Portfolio · Precision Guide Lapidus · Precision MIS Bunion · Prolia · Puraply · Puraply Antimicrobial · Qutenza · RENASYS GO v2 HOME · REVCON · Rybelsus · SALVATION · STRAVIX · Santyl · Senza · SkinTE · SonicOne · Stravix · Supera peripheral stent system · Tresiba · Trintellix · URGOK2 · Uloric · VA-LCP PLATES & SCREWS · VANTAGE · VRAYLAR · VersaWrap · Wegovy · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Foot & ankle surgery podiatrists within 10 mi
125
Per 100K population
14.9
County median income
$141,446
Nearest hospital
KAISER FOUNDATION HOSPITAL - SAN FRANCISCO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vartivarian is a clinical cardiology specialist, with above-average Medicare volume (top 27% in CA), with low-engagement industry engagement in the top 12% of CA peers, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vartivarian experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Vartivarian performed 519 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vartivarian receive payments from pharmaceutical companies?
Yes. Dr. Vartivarian received a total of $10,706 from 50 companies across 236 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vartivarian's costs compare to other foot & ankle surgery podiatrists in San Francisco?
Dr. Vartivarian's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vartivarian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Foot & Ankle Surgery Podiatrists in San Francisco
Browse foot & ankle surgery podiatrists in San Francisco ranked by procedure volume and transparency data.
Highest volume
Top Foot & Ankle Surgery Podiatrists in CA
Foot & ankle surgery podiatrists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Foot & Ankle Surgery Podiatrists in CA
Which CA foot & ankle surgery podiatrists receive the most from drug and device companies.
By company
Smith+Nephew, Inc. Payments to Doctors
See all physicians who received payments from Smith+Nephew, Inc.
By company
Osiris Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Osiris Therapeutics Inc.
By company
Voom Medical Devices, Inc. Payments to Doctors
See all physicians who received payments from Voom Medical Devices, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology